GIM
TAK icon

Glenmede Investment Management’s Takeda Pharmaceutical TAK Stock Holding History

Glenmede Investment Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$508K Buy
34,677
+3,824
+12% +$56.8K ﹤0.01% 922
2025
Q2 		$477K Buy
+30,853
New +$456K ﹤0.01% 942

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Glenmede Investment Management's TAK Position: Q3 2025 in Review

Glenmede Investment Management increased its Takeda Pharmaceutical (TAK) stake by 12% in Q3 2025, buying an estimated $56.8K and bringing the position to 34,677 shares worth $508K. The position accounts for ﹤0.01% of the portfolio, ranked #922.

Glenmede Investment Management first reported a position in TAK in Q2 2025 and has held it in 2 quarters since. 329 funds tracked by Wall St. Rank hold TAK as of Q3 2025.

  • Glenmede Investment Management held 34,677 shares of Takeda Pharmaceutical worth $508K as of Q3 2025.
  • Glenmede Investment Management bought 3,824 Takeda Pharmaceutical shares in Q3 2025, an estimated $56.8K.
  • Takeda Pharmaceutical made up ﹤0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #922 holding.
  • Glenmede Investment Management first reported a position in Takeda Pharmaceutical in Q2 2025 and has held it in 2 quarters since.
  • 329 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.